Inovio Pharmaceuticals INO
NASDAQ INO
$1.19 -0.02 (-1.65%)
As of: Oct 2, 2026 · 10:08 AM EDT

Inovio Pharmaceuticals (INO) Total Current Liabilities (2010 - 2026)

Updated

Inovio Pharmaceuticals (INO) posted Total Current Liabilities of $39.92 million for Q2 2026, up 25.9% from $31.71 million a year earlier and up 5.3% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Inovio Pharmaceuticals' Total Current Liabilities came in at $43.67 million, up 23.6% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
  • In prior years, Inovio Pharmaceuticals' Total Current Liabilities was $35.33 million in FY2024 (-17.0%), $42.57 million in FY2023 (-56.1%), $96.87 million in FY2022 (+47.3%) and $65.74 million in FY2021 (+57.6%).
  • Quarterly Total Current Liabilities has run from a low of $23.4 million in Q1 2024 to a high of $131.06 million in Q2 2022 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last six quarters, with growth averaging 32.4% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2025, with growth of 197.1%; the weakest was Q2 2023, with a decline of 60.4%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $37.92 million (Q1 2026), $43.67 million (Q4 2025) and $69.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Inovio Pharmaceuticals 99.58 Mn 99.58 Mn - 39.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.92 Mn
Mar 31, 2026 37.92 Mn
Dec 31, 2025 43.67 Mn
Sep 30, 2025 69.82 Mn
Jun 30, 2025 31.71 Mn
Mar 31, 2025 27.33 Mn
Dec 31, 2024 35.33 Mn
Sep 30, 2024 23.50 Mn
Jun 30, 2024 26.40 Mn
Mar 31, 2024 23.40 Mn
Dec 31, 2023 42.57 Mn
Sep 30, 2023 43.71 Mn
Jun 30, 2023 51.93 Mn
Mar 31, 2023 55.15 Mn
Dec 31, 2022 96.87 Mn
Sep 30, 2022 94.91 Mn
Jun 30, 2022 131.06 Mn
Mar 31, 2022 59.36 Mn
Dec 31, 2021 65.74 Mn
Sep 30, 2021 51.38 Mn
API Access

Inovio Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INO&period=max&api_key=YOUR_API_KEY